Crossmark

Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT

Crossref DOI link: https://doi.org/10.1038/s41409-022-01881-6

Published Online: 2022-11-29

Published Print: 2023-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moiseev, Ivan https://orcid.org/0000-0002-4332-0114
Ambron, Pascale

Badoglio, Manuela

Peczynski, Christophe https://orcid.org/0000-0002-3829-0088
Basak, Grzegorz https://orcid.org/0000-0003-3858-8180
Koenecke, Christian https://orcid.org/0000-0001-7025-1735
Schoemans, Helene https://orcid.org/0000-0002-7568-8239
Penack, Olaf https://orcid.org/0000-0003-4876-802X
Peric, Zinaida https://orcid.org/0000-0001-9458-8025
License Information

Text and Data Mining valid from 2022-11-29

Version of Record valid from 2022-11-29
More Information

Article History

Received: 22 September 2022

Revised: 15 November 2022

Accepted: 17 November 2022

First Online: 29 November 2022

Competing interests

: The authors declare no competing interests.